Pandion Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
Merck To Acquire Pandion Therapeutics For $60 Per Share In Cash
Article By: The Fly
Thursday, February 25, 2021 8:45 AM EDT
Merck and Pandion Therapeutics announced that the companies have entered into a definitive agreement, under which Merck, through a subsidiary, will acquire Pandion.
In this article: MRK, PAND
Read

Latest Tweets for $PAND

No tweets yet!